Market Place
Sourcing Support
Veradermics to Present at June Investor Conferences
28 May 2026 //
BUSINESSWIRE
Veradermics Presents Phase 2/3 VDPHL01 Data at Hair Congress
27 May 2026 //
BUSINESSWIRE
Veradermics Presents VDPHL01 Posters at Music City SCALE 2026
14 May 2026 //
BUSINESSWIRE
Veradermics Reports Q1 2026 Financial and Clinical Progress
12 May 2026 //
BUSINESSWIRE
Veradermics Prices Upsized Public Offering and Private Placement
29 Apr 2026 //
BUSINESSWIRE
Veradermics Tests Oral Rogaine for Hair Growth in First Trial
27 Apr 2026 //
ENDPOINTS
Veradermics` VDPHL01 Drives Hair Growth in Phase 2/3 Trial
27 Apr 2026 //
BUSINESSWIRE
Veradermics Announces Launch of Public Offering
27 Apr 2026 //
BUSINESSWIRE
Veradermics Reports Q4 and Full Year 2025 Financial Results
30 Mar 2026 //
BUSINESSWIRE
Veradermics Showcases VDPHL01, Patient Experiences at 2026 AAD
18 Mar 2026 //
BUSSINESSWIRE
Veradermics To Participate In Upcoming March Investor Conferences
03 Mar 2026 //
BUSINESSWIRE
Veradermics Finishes Phase 3 Trial Enrollment For VDPHL01
09 Feb 2026 //
BUSINESSWIRE
Veradermics Locks In $256M IPO, Shares Spike
05 Feb 2026 //
FIERCE PHARMA
Eikon, Veradermics Announce IPO Targets Amid Cautious Optimism
29 Jan 2026 //
BIOSPACE
Veradermics, Eikon Eye Public Market Debut As IPO Tap Opens
12 Jan 2026 //
BIOSPACE
Veradermics Advances VDPHL01 Trial For Male Pattern Hair Loss
11 Dec 2025 //
BUSINESSWIRE
Veradermics VDPHL01 Enters Phase 2/3 for Female Pattern Hair Loss
18 Nov 2025 //
BUSINESSWIRE
Veradermics Secures $150M For VDPHL01 Phase 3 Trials In Hair
16 Oct 2025 //
BUSINESS WIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.